Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

Philip Raskin, L. Klaff, J. McGill, S. A. South, P. Hollander, N. Khutoryansky, P. M. Hale

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalDiabetes care
Volume26
Issue number9
DOIs
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this